These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5715725)

  • 61. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood.
    Velik-Salchner C; Schnürer C; Fries D; Müssigang PR; Moser PL; Streif W; Kolbitsch C; Lorenz IH
    Thromb Res; 2006; 117(5):597-602. PubMed ID: 15985284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hemostasis in plasmocytomas. Preliminary observations on the inhibiting activities demonstrable in the plasma and serum protein fractions.
    Recalcati P; Besana C; Ballarino M
    Haematol Lat; 1967; 10(4):317-35. PubMed ID: 5597878
    [No Abstract]   [Full Text] [Related]  

  • 63. [Blood coagulation activities on the vascular intima. 9. Intimal antithrombin and atherosclerosis in man].
    Ota G; Tsubokawa Y
    Igaku To Seibutsugaku; 1968 Sep; 77(3):95-9. PubMed ID: 5750583
    [No Abstract]   [Full Text] [Related]  

  • 64. [Normal values of leukocytes, basophilic granulocytes and antithrombin activities in blood donors].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):87-97. PubMed ID: 4121134
    [No Abstract]   [Full Text] [Related]  

  • 65. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anticoagulant properties of three mucopolysaccharides used in rheumatology.
    Bauer F; Schulz P; Reber G; Bouvier CA
    Thromb Haemost; 1983 Oct; 50(3):652-5. PubMed ID: 6228031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antithrombin III assays.
    Messmore HL; Fareed J
    JAMA; 1978 Jul; 240(4):345-6. PubMed ID: 660861
    [No Abstract]   [Full Text] [Related]  

  • 69. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Various aspects of blood coagulation in chronic pancreatitis with special reference to the antithrombin test].
    Facchini G; Fontana G; Cremonini GP; Scarcella D
    G Clin Med; 1969 Jan; 50(1):75-89. PubMed ID: 5386457
    [No Abstract]   [Full Text] [Related]  

  • 71. The rivanol method for the quantitative determination of antithrombin III in plasma.
    Yue RH; Starr T; Gertler MM
    Thromb Diath Haemorrh; 1974 Jun; 31(3):439-51. PubMed ID: 4423843
    [No Abstract]   [Full Text] [Related]  

  • 72. On the nature of antithrombin V.
    Vinazzer H; Reinhardt F
    Thromb Diath Haemorrh; 1968 Nov; 20(1):234-46. PubMed ID: 5708894
    [No Abstract]   [Full Text] [Related]  

  • 73. [Antithrombin III during coagulation in vitro].
    Aiach M; Andreux JP; Fiessinger JN; Beuvin J; Leclerc M
    Ann Pharm Fr; 1976; 34(1-2):43-50. PubMed ID: 970875
    [No Abstract]   [Full Text] [Related]  

  • 74. Oral contraceptives and anti-thrombin-3 activity: a new method of antithrombin estimation.
    Howie PW; Prentice CR; McNicol GP
    Clin Sci; 1972 Jul; 43(1):2P. PubMed ID: 5064809
    [No Abstract]   [Full Text] [Related]  

  • 75. [The effect of adrenal gland hormones on the thrombogenic properties of the blood in experimental hypercholesteremia in rabbits].
    Rassokhin VM; Shershevskiĭ MG
    Patol Fiziol Eksp Ter; 1966; 10(6):80-1. PubMed ID: 5246530
    [No Abstract]   [Full Text] [Related]  

  • 76. [Antithrombin activity of blood in experimental extrahepatic cholestasis].
    Burnazian RA; Kiianov VI; Petrishchev NN
    Zh Eksp Klin Med; 1976; 16(2):22-8. PubMed ID: 973498
    [No Abstract]   [Full Text] [Related]  

  • 77. Thrombin inhibition by malignant and normal cells: a cell-bound antithrombin effect.
    Tullis JL; Honegger H; Fleischaker O; Hewitt L; Kenney D; Chao FC
    Cancer; 1981 Sep; 48(5):1177-82. PubMed ID: 7272951
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Technique of coagulation diagnostics in the clinical laboratory. IV].
    Simon KH
    Med Monatsschr; 1970 Jun; 24(6):273. PubMed ID: 5525116
    [No Abstract]   [Full Text] [Related]  

  • 79. [Determination of fibrinogen by thrombin time - with special reference to the effect of anti-thrombin].
    Isobe J; Taharaguchi T; Watanabe H; Shima E; Hamai Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):109. PubMed ID: 4475718
    [No Abstract]   [Full Text] [Related]  

  • 80. Antithrombin 3 and diseases.
    Von Kaulla E; Von Kaulla KN
    Am J Clin Pathol; 1967 Jul; 48(1):69-80. PubMed ID: 5339224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.